Our proprietary data analysis and interpretation pipelines are a key pillar of our service offerings for gene therapy safety assessment. Our highly-accomplished bioinformatics team analyzes primary data from our assays to gain deep biological insights to answer specific safety concerns.
This includes integration site analysis for pre-clinical and clinical studies, On-/off-target analysis for gene therapy safety assessment, vector quality control and immune repertoire analysis.
Read our latest press releases and announcements below.
GeneWerk will expand capabilities to meet rapidly growing demand for cell and gene therapy...